Table 4 Survival of patients with breast cancer according to different stages and molecular subtypes
Characteristic | 5-year OS rate [% (95% CI)] | 5-year CSS rate [% (95% CI)] |
|---|---|---|
Overall | 89.4 (88.5–90.3) | 90.3 (89.4–91.1) |
Stage | ||
 I | 96.5 (95.4–97.4) | 97.1 (96.1–97.9) |
 II | 91.6 (90.3–92.7) | 92.6 (91.4–93.6) |
 III | 74.8 (71.0–78.2) | 75.6 (71.8–78.9) |
 IV | 40.7 (31.0–50.1) | 42.7 (32.8–52.1) |
Molecular subtype | ||
 Luminal A | 92.6 (91.5–93.6) | 93.2 (92.1–94.2) |
 Luminal B | 88.4 (85.3–90.9) | 89.1 (86.1–91.5) |
 HER2 | 83.6 (79.3–87.0) | 85.4 (81.3–88.7) |
 Triple-negative | 82.9 (79.3–85.9) | 83.5 (79.9–86.4) |